The invention provides compositions and methods for treating inflammatory condition of the gastrointestinal (GI) tract, specifically those related to Inflammatory Bowel Disease (IDB). Compositions according to the invention due to their specific content of cannabinoids and methods comprising specific modes of administration thereof are particularly applicable to the treatment of the two major IDBs, Crohn's disease and colitis.